Latest Articles

Publication Date
Diagnostic Accuracy of Endometrial Sampling Methods for Determining Histologic Type and Grade in Endometrial Cancer: A Retrospective Cohort Study - Cureus

Diagnostic Accuracy of Endometrial Sampling Methods for Determining Histologic Type and Grade in Endometrial Cancer: A Retrospective Cohort Study Cureus

Published: Oct. 26, 2025, 10:10 a.m.
Bindi Irwin's Message For Women In Post Emergency Surgery Health Update - MSN

Bindi Irwin's Message For Women In Post Emergency Surgery Health Update MSN

Published: Oct. 26, 2025, 6:59 a.m.
Minister for Health Announces Accelerated Clinical Pathway in New Endometriosis Framework for Sufferers - Emegypt

Minister for Health Announces Accelerated Clinical Pathway in New Endometriosis Framework for Sufferers Emegypt

Published: Oct. 26, 2025, 6:53 a.m.
Stacey Rusch Supports Wendy Osefo Through Legal Ordeal - Urban Woman Magazine

Stacey Rusch Supports Wendy Osefo Through Legal Ordeal Urban Woman Magazine

Published: Oct. 25, 2025, 4:03 p.m.
What Is Endometriosis and How Does It Affect Women? - Urban Woman Magazine

What Is Endometriosis and How Does It Affect Women? Urban Woman Magazine

Published: Oct. 25, 2025, 12:43 p.m.
Celebrities That Have Endometriosis: Halsey, Barbara Palvin, Mandy Moore - MSN

Celebrities That Have Endometriosis: Halsey, Barbara Palvin, Mandy Moore MSN

Published: Oct. 25, 2025, 11:37 a.m.
Shrutika Arjun shares her surgery journey and recovery after endometriosis treatment: I'm advised to take a 45-day break - MSN

Shrutika Arjun shares her surgery journey and recovery after endometriosis treatment: I'm advised to take a 45-day break MSN

Published: Oct. 25, 2025, 7:03 a.m.
Amy Schumer's Shocking New Look After 30 Lb Weight Loss - Soy Carmín

Amy Schumer's Shocking New Look After 30 Lb Weight Loss Soy Carmín

Published: Oct. 25, 2025, 1:16 a.m.
Lowe's has a BOGO deal that gets you a free Bosch power tool - Mashable

Lowe's has a BOGO deal that gets you a free Bosch power tool Mashable

Published: Oct. 24, 2025, 5:14 p.m.
Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors - The Manila Times

Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors The Manila Times

Published: Oct. 24, 2025, 3:57 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!